[go: up one dir, main page]

WO2005079751A3 - Oral pharmaceutical compositions of candesartan cilexetil - Google Patents

Oral pharmaceutical compositions of candesartan cilexetil Download PDF

Info

Publication number
WO2005079751A3
WO2005079751A3 PCT/IB2005/000148 IB2005000148W WO2005079751A3 WO 2005079751 A3 WO2005079751 A3 WO 2005079751A3 IB 2005000148 W IB2005000148 W IB 2005000148W WO 2005079751 A3 WO2005079751 A3 WO 2005079751A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
candesartan cilexetil
oral pharmaceutical
cilexetil
candesartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/000148
Other languages
French (fr)
Other versions
WO2005079751A2 (en
Inventor
Romi Barat Singh
Girish K Karanth
Vishnubhotla Naga Prasad
Sanjeev Kumar Sethi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to EP05702309A priority Critical patent/EP1711168A2/en
Publication of WO2005079751A2 publication Critical patent/WO2005079751A2/en
Publication of WO2005079751A3 publication Critical patent/WO2005079751A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical compositions of candesartan cilexetil that include fatty substances and processes for their preparation.
PCT/IB2005/000148 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil Ceased WO2005079751A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05702309A EP1711168A2 (en) 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN127DE2004 2004-01-23
IN127/DEL/2004 2004-01-23

Publications (2)

Publication Number Publication Date
WO2005079751A2 WO2005079751A2 (en) 2005-09-01
WO2005079751A3 true WO2005079751A3 (en) 2006-03-30

Family

ID=34878773

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000148 Ceased WO2005079751A2 (en) 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil

Country Status (2)

Country Link
EP (1) EP1711168A2 (en)
WO (1) WO2005079751A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494134B (en) * 2006-06-20 2015-08-01 Siegfried Generics Int Ag Composition granule and tablet containing candesartan cilexetil and process to fabricate the tablet
AU2007293727A1 (en) * 2006-09-05 2008-03-13 Astrazeneca Ab Pharmaceutical composition comprising candesartan cilexetil
WO2008045006A1 (en) * 2006-10-11 2008-04-17 Fako Ilaclari A. S. Formulations of candesartan
US20100041644A1 (en) * 2006-11-28 2010-02-18 Laboratorios Liconsa, S. A. Stabilized solid pharmaceutical composition of candesartan cilexetil
WO2008084504A2 (en) * 2007-01-12 2008-07-17 Rubicon Research Private Limited Pharmaceutical compositions of angiotensin ii receptor blockers
EP1952806A1 (en) 2007-02-01 2008-08-06 Helm AG Process for the preparation of adsorbates of candesartan
PL384680A1 (en) * 2007-03-28 2008-09-29 Zak & Lstrok Ady Farmaceutyczn Pharmaceutical composition containing cylexyethyl candesarthan and its production method
RU2010104960A (en) * 2007-08-01 2011-09-10 Тева Фармасьютикал Индастриес Лтд. (Il) PHARMACEUTICAL COMPOSITION OF CANDESARTAN
DE102007052070A1 (en) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg candesartancilexetil
ES2377552T3 (en) * 2008-09-17 2012-03-28 Helm Ag Easily dissolved and stable compositions of candesartan cilexetil prepared with a wet granulation
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
ES2364011B1 (en) 2009-11-20 2013-01-24 Gp Pharm, S.A. CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
PT2663294E (en) 2011-01-11 2016-01-25 Capsugel Belgium Nv New hard capsules comprising pullulan
JP6231553B2 (en) 2012-05-07 2017-11-15 バイエル ファーマ アクチエンゲゼルシャフト Process for producing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
CN103127012B (en) * 2013-02-17 2015-04-22 杭州澳医保灵药业有限公司 Ebastine dispersible tablet and preparation method thereof
ES3033915T3 (en) 2017-04-14 2025-08-11 Capsugel Belgium Nv Pullulan capsules
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
CN117442577B (en) * 2023-12-21 2024-03-15 山东则正医药技术有限公司 Candesartan cilexetil microchip and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546358A2 (en) * 1991-11-20 1993-06-16 Takeda Chemical Industries, Ltd. Pharmaceutical compositions with angiotensin-II-antagonistic activity
WO1999056734A2 (en) * 1998-05-06 1999-11-11 Hexal Ag Transdermal therapeutic system for the administration of candesartan
EP1153613A1 (en) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
EP1312379A1 (en) * 2000-08-25 2003-05-21 Takeda Chemical Industries, Ltd. Fibrinogen lowering agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546358A2 (en) * 1991-11-20 1993-06-16 Takeda Chemical Industries, Ltd. Pharmaceutical compositions with angiotensin-II-antagonistic activity
WO1999056734A2 (en) * 1998-05-06 1999-11-11 Hexal Ag Transdermal therapeutic system for the administration of candesartan
EP1153613A1 (en) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
EP1312379A1 (en) * 2000-08-25 2003-05-21 Takeda Chemical Industries, Ltd. Fibrinogen lowering agents

Also Published As

Publication number Publication date
EP1711168A2 (en) 2006-10-18
WO2005079751A2 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
WO2005079751A3 (en) Oral pharmaceutical compositions of candesartan cilexetil
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
IL184114A0 (en) Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions
SI1695710T1 (en) Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
WO2006131591A3 (en) An entacapone-containing oral dosage form
PL1916994T3 (en) Manufacturing of quick release pharmaceutical composition of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
SI1752443T1 (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
PL1695709T3 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
PL1701698T3 (en) Directly compressible pharmaceutical composition for the oral admimistration of cci-779
IL183986A0 (en) Pharmaceutical compounds and compositions
IL191935A0 (en) Water-soluble benzoazepine compound and its pharmaceutical composition
WO2008054808A3 (en) Elvucitabine pharmaceutical compositions
EP2644614A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
WO2005070398A3 (en) Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents
WO2005084648A8 (en) Pharmaceutical compositions comprising candesartan cilexetil
EP1637167A3 (en) New injectable formulations containing progesterone
WO2008033930A3 (en) Vinca derivatives
WO2007110765A3 (en) Processes for the preparation of octreotide
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
WO2007139833A3 (en) Imidazoazephinone compounds
WO2009060064A3 (en) Pharmaceutical formulations for the oral administration of ppi
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
PT2474528E (en) Antineoplasic compounds and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005702309

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 4234/DELNP/2006

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWP Wipo information: published in national office

Ref document number: 2005702309

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2005702309

Country of ref document: EP